NASDAQ: INGN |
| Healthcare / Medical Devices & Instruments / USA |
25.89 | +0.5300 | +2.09% | Vol 156.60K | 1Y Perf -61.03% |
May 17th, 2022 16:00 DELAYED |
BID | 18.00 | ASK | 35.09 | ||
Open | 25.70 | Previous Close | 25.36 | ||
Pre-Market | - | After-Market | 25.89 | ||
- - | - -% |
Target Price | 36.33 | Analyst Rating | Moderate Buy 2.40 | |
Potential % | 40.32 | Finscreener Ranking | ★★★★ 52.56 | |
Insiders Trans % 3/6/12 mo. | -100/-100/-100 | Value Ranking | ★★★★+ 61.36 | |
Insiders Value % 3/6/12 mo. | -100/-100/-100 | Growth Ranking | ★★ 46.32 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/-100 | Income Ranking | — - | |
Price Range Ratio 52W % | 5.65 | Earnings Rating | Strong Buy | |
Market Cap | 591.20M | Earnings Date | 5th May 2022 | |
Alpha | -0.02 | Standard Deviation | 0.17 | |
Beta | 1.01 |
Today's Price Range 25.5825.95 | 52W Range 22.5182.35 | 5 Year PE Ratio Range -108.40302.90 |
Summary:
Neutral
Technical Indicators: | Neutral |
Moving Averages: | Sell |
Performance | |||
---|---|---|---|
1 Week | 13.16% | ||
1 Month | -5.99% | ||
3 Months | -11.03% | ||
6 Months | -23.88% | ||
1 Year | -61.03% | ||
3 Years | -63.74% | ||
5 Years | -68.31% | ||
10 Years | - |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 0.64 | |||
ROE last 12 Months | -5.70 | |||
ROA (5Y Avg) | 0.40 | |||
ROA last 12 Months | -4.29 | |||
ROC (5Y Avg) | 5.21 | |||
ROC last 12 Months | -5.24 | |||
Return on invested Capital Q | -3.64 | |||
Return on invested Capital Y | -5.61 | |||
Assets Turnover | 0.80 | |||
Receivables Turnover | 10.70 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
-28.70 | ||||
1.61 | ||||
1.65 | ||||
214.00 | ||||
-28.40 | ||||
0.12 | ||||
2.16 | ||||
15.69 | ||||
379.94M | ||||
Forward PE | -60.38 | |||
PEG | 4.94 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
4.30 | ||||
5.30 | ||||
0.06 | ||||
0.07 | ||||
- | ||||
Leverage Ratio | 1.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
48.80 | ||||
-0.60 | ||||
5.70 | ||||
3.80 | ||||
-5.76 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
351.46M | ||||
15.39 | ||||
-1.66 | ||||
8.45 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2022 | -0.48 | -0.38 | 20.83 |
Q04 2021 | -0.74 | -1.01 | -36.49 |
Q03 2021 | -0.29 | 0.53 | 282.76 |
Q02 2021 | -0.13 | 0.22 | 269.23 |
Q01 2021 | -0.28 | -0.03 | 89.29 |
Q04 2020 | -0.28 | -0.23 | 17.86 |
Q03 2020 | -0.02 | -0.08 | -300.00 |
Q02 2020 | -0.08 | 0.12 | 250.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
6/2022 QR | -0.39 | 0.00 | - |
9/2022 QR | -0.31 | -106.67 | Negative |
12/2022 FY | -1.63 | -328.95 | Negative |
12/2023 FY | -0.42 | -950.00 | Negative |
Next Report Date | - |
Estimated EPS Next Report | -0.47 |
Estimates Count | 4 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 156.60K |
Shares Outstanding | 22.84K |
Shares Float | 10.56M |
Trades Count | 3.47K |
Dollar Volume | 4.04M |
Avg. Volume | 187.93K |
Avg. Weekly Volume | 188.88K |
Avg. Monthly Volume | 200.06K |
Avg. Quarterly Volume | 174.83K |
Inogen Inc (NASDAQ: INGN) stock closed at 25.89 per share at the end of the most recent trading day (a 2.09% change compared to the prior day closing price) with a volume of 156.60K shares and market capitalization of 591.20M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 938 people. Inogen Inc CEO is Scott Wilkinson.
The one-year performance of Inogen Inc stock is -61.03%, while year-to-date (YTD) performance is -23.85%. INGN stock has a five-year performance of -68.31%. Its 52-week range is between 22.51 and 82.35, which gives INGN stock a 52-week price range ratio of 5.65%
Inogen Inc currently has a PE ratio of -28.70, a price-to-book (PB) ratio of 1.61, a price-to-sale (PS) ratio of 1.65, a price to cashflow ratio of 214.00, a PEG ratio of 2.32, a ROA of -4.29%, a ROC of -5.24% and a ROE of -5.70%. The company’s profit margin is -5.76%, its EBITDA margin is 5.70%, and its revenue ttm is $351.46 Million , which makes it $15.39 revenue per share.
Of the last four earnings reports from Inogen Inc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.47 for the next earnings report. Inogen Inc’s next earnings report date is -.
The consensus rating of Wall Street analysts for Inogen Inc is Moderate Buy (2.4), with a target price of $36.33, which is +40.32% compared to the current price. The earnings rating for Inogen Inc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Inogen Inc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Inogen Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 1.37, CCI20 : 19.56, Chaikin Money Flow : -0.04, MACD : -1.33, Money Flow Index : 46.59, ROC : 2.41, RSI : 46.61, STOCH (14,3) : 82.84, STOCH RSI : 1.00, UO : 49.41, Williams %R : -17.16), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Inogen Inc in the last 12-months were: Alison Bauerlein (Option Excercise at a value of $742 435), Alison Bauerlein (Sold 19 264 shares of value $1 493 703 ), Bart Sanford (Option Excercise at a value of $0), Benjamin M. Anderson-Ray (Sold 4 516 shares of value $156 619 ), Brenton Taylor (Option Excercise at a value of $316 570), Brenton Taylor (Sold 7 942 shares of value $595 808 ), Loren L. Mcfarland (Option Excercise at a value of $17 435), Nabil Shabshab (Option Excercise at a value of $0), Raymond O. Huggenberger (Option Excercise at a value of $716 613), Raymond O. Huggenberger (Sold 24 681 shares of value $1 522 417 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
CEO: Scott Wilkinson
Telephone: +1 805 562-0500
Address: 326 Bollay Drive, Goleta 93117, CA, US
Number of employees: 938
Tue, 11 Jan 2022 15:24 GMT Inogen (INGN) Receives a Hold from Leerink Partners
- TipRanks. All rights reserved.Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. CBOE EDGX Top real-time data for Premium users, NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Technology and data provided by TeleTrader. Conditions of Use. The regulations of the respective stock are to be observed. Copyright © 2022. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer. The Cryptocurrency Market real-time data provided by Cryptocompare.com
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.